The growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 4, 2012, Pages e7-

  Garau, Pietro ^a   Vacca, Alessandra ^a   Calvisi, Stefania ^a   Matta, Gildo ^b   De Candia, Gianfranco ^a   Cauli, Alberto ^a   Mathieu, Alessandro ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b BROTZU HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; DIURETIC AGENT; ENOXAPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; SILDENAFIL; SITAXSENTAN; WARFARIN;

ADULT; ARTERY DILATATION; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPOKINESIA; HEART VENTRICLE SEPTUM; HUMAN; INTERNATIONAL NORMALIZED RATIO; LARGE PULMONARY ARTERY DILATATION; LETTER; PATIENT ASSESSMENT; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; VASODILATATION; WALKING;

EID: 84857034422     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.10.007     Document Type: Letter

References (7)

1. Mavrogeni S., Vassilopoulos D. Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases?. Semin Arthritis Rheum 2011, 41(3):488-496.
2. Tzelepis G.E., Kelekis N., Plastiras S.C., Mitseas P., Economopoulos N., Kampolis C., et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007, 56:3827-3836.
3. Bezante G.P., Rollando D., Sessarego M., Panico N., Setti M., Filaci G., et al. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. J Rheumatol 2007, 34:2431-2437.
4. Allanore Y., Meune C., Vignaux O., Weber S., Legmann P., Kahan A. Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and tissue-Doppler echography study. J Rheumatol 2006, 33:2464-2469.
5. Hachulla A.L., Launay D., Gaxotte V., de Groote P., Lamblin N., Devos P., et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009, 68:1878-1884.
6. Vignaux O., Allanore Y., Meune C., Pascal O., Duboc D., Weber S., et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis 2005, 64:1268-1273.
7. Benza R., Biederman R., Murali S., Gupta H. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol 2008, 18:1683-1692.